The robotics giant revealed on an earnings call that it won FDA clearance for several cardiac procedures and is also ramping ...

Integra LifeSciences has recalled wound and burn treatments over issues linked to 14 serious injuries, the Food and Drug Administration said Thursday. The FDA published an early alert after Integra ...

The nonprofit said technologies like ChatGPT have suggested incorrect diagnoses, invented body parts and otherwise provided ...

AdvaMed CEO Scott Whitaker and Mick Farrell, new board chair of the trade group, weighed in on important issues for the medtech industry one year into the Trump administration.

Pricing challenges in Abbott’s nutrition business and lower than expected sales of continuous glucose monitors drove down the ...

Medtronic’s investment is contingent on Anteris completing a proposed $200 million public stock offering.

Boston Scientific has told customers to stop using certain stents linked to three deaths, the Food and Drug Administration ...

Penumbra is expected to give Boston Scientific more of a presence in the vascular surgery market, with little overlap between ...

Abbott’s latest CE mark for its TactiFlex Duo system was based on a clinical trial conducted in the European Union, United ...

The assistant, which can answer health questions and help schedule appointments, comes on the heels of other health-focused AI tools from OpenAI and Anthropic.

Cardiovascular was the only business unit to grow by double digits last year, helping to fuel the overall medical device business to top $33 billion.

Hollingshead, the former CEO of Insulet, will lead BVI as it uses a $1 billion financing to support its global eye care business.